6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahach, VF; Talanov, SA | 1 |
| Ha, JY; Han, JY; Hyun, DH; Kang, UJ; Kim, KH; Paek, SH; Shim, JH; Son, JH; Yoon, SH; Zhuang, X | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
[Antioxidants prevent experimental hemiparkinsonism in rats].
Topics: Animals; Antioxidants; Behavior, Animal; Chromans; Disease Models, Animal; Dopamine; Male; Melatonin; Neurons; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Inbred WKY; Substantia Nigra; Ubiquinone | 2008 |
The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Cells, Cultured; Chaperonin 60; Chromans; Citrate (si)-Synthase; Cytochromes b5; Dopaminergic Neurons; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex IV; Enzyme Assays; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Mitochondria; Mitochondrial Proteins; Oncogene Proteins; Oxidative Stress; Oxygen Consumption; Parkinsonian Disorders; Protein Deglycase DJ-1; Protein Kinases | 2011 |